调节GABAergic系统作为中风治疗的治疗选择
Milka Perovic1, Damjan Pavlovic2, Zoe Palmer2
1Department of Neurobiology, Institute for Biological Research "Sinisa Stankovic" - National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Experimental neurology
|November 10, 2024
概括
脑卒中恢复研究正在将重点从兴奋毒性转移到抑制性γ-氨基黄油酸 (GABA) 系统. 调节GABAergic神经递质,特别是与神经类固醇,显示了增强功能恢复和中风后的神经修复的承诺.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在全球范围内,中风仍然是导致死亡和残疾的主要原因,社会成本不断增加.
- 目前针对缺血性损伤的中风疗法在减少长期发病率和死亡率方面有效性有限.
- 新出现的证据强调了抑制性γ-氨基黄油酸 (GABA) 系统在中风恢复中的关键作用,将重点从谷氨酸刺激毒性转移到谷氨酸刺激毒性.
研究的目的:
- 审查GABAergic神经传递变化与中风恢复之间的相关性.
- 概述GABAergic系统调节剂,特别是神经类固醇,用于中风治疗.
- 讨论GABA信号向治疗对人类神经修复的潜力.
主要方法:
- 审查现有的科学文献,包括动物和人类临床研究.
- 对中风后GABAergic系统变化的证据分析.
- 检查神经类固醇和其他影响中风病原和可塑性的调节剂.
主要成果:
- 在中风后的功能恢复中,GABAergic神经递质起着重要作用.
- 神经类固醇和其他GABAergic调节剂显示出影响中风病原性,可塑性和认知衰退的潜力.
- 年龄和性别被确定为影响中风病理生理学和治疗策略的关键因素.
结论:
- 调节抑制性GABA系统为中风恢复提供了一个有希望的治疗途径.
- 针对GABA信号,特别是神经类固醇,可能会导致更有效的神经修复疗法.
- 对神经化学变化和GABA系统的进一步研究对于开发先进的中风干预措施至关重要.
关键词:
衰老的衰老 衰老的衰老对于GABA来说,这是一个很好的选择.在GABA(A) 受体上.在 GABAergic 传输过程中,有活性的 GABA.这是神经类固醇.性差异性差异性差异性差异性差异性差异性差一次性中风,中风.脑卒中恢复 脑卒中恢复的方法更多相关视频
07:34Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
1.8K
05:00Transplantation of Human Stem Cell-Derived GABAergic Neurons into the Early Postnatal Mouse Hippocampus to Mitigate Neurodevelopmental Disorders
Published on: November 11, 2022
2.4K
相关概念视频
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
334
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
334
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
253
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
253
01:14Antiepileptic Drugs: Glutamate Antagonists
284
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
284
01:20Antiepileptic Drugs: Potassium Channel Activators
147
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
147
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
01:22Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165